4//SEC Filing
Chakma Justin 4
Accession 0001415889-24-029162
CIK 0001671858other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:41 PM ET
Size
8.8 KB
Accession
0001415889-24-029162
Insider Transaction Report
Form 4
Chakma Justin
Chief Business Officer
Transactions
- Exercise/Conversion
Common Stock
2024-12-10$0.84/sh+50,000$42,000→ 186,380 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-12-10−50,000→ 0 totalExercise: $0.84Exp: 2029-07-04→ Common Stock (50,000 underlying) - Sale
Common Stock
2024-12-10$13.15/sh−50,000$657,625→ 136,380 total
Footnotes (2)
- [F1]The weighted average sale price for the transaction reported was $13.1525, and the range of prices were between $12.95 and $13.42. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
- [F2]Immediately exercisable.
Documents
Issuer
ARS Pharmaceuticals, Inc.
CIK 0001671858
Entity typeother
Related Parties
1- filerCIK 0001951238
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 5:41 PM ET
- Size
- 8.8 KB